AccessibilityHelpAbout Us
Covalon Technologies logo

Covalon Technologies(TSXV) COV

Market CapCA$110.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)+43%
5 Year+43%
1 Year+94%
1 Month+73%
CA$3.99
+7.84%
+0.29Today
Covalon Technologies last closing stock price
MetricPriceDate
Last closeCAD 3.992026-09-21
Covalon Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.83%CAD 3.602026-09-14
1 month+73.48%CAD 2.302026-08-21
3 month+77.33%CAD 2.252026-06-23
Year to date+129.31%CAD 1.742025-12-31
1 year+94.32%CAD 2.052025-09-19
3 year+194.83%CAD 1.352023-09-21
5 year+42.5%CAD 2.802021-09-22
Since inception+42.5%CAD 2.802004-09-03

Covalon Technologies Financials at a Glance

Market Cap

CA$110.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$34.35M

Net Income (TTM)

CA$4.39M

EPS (TTM)

CA$0.16

P/E Ratio

25.09

Dividend

CA$0.00

Beta (Volatility)

0.22 (Low)

Price

CA$3.99

Volume

93,101

Open

CA$3.85

Previous Close

CA$3.99

Daily Range

CA$3.85 - CA$4.01

52-Week Range

CA$1.55 - CA$4.01

Estimated Earnings Date

Dec 10, 2026

COV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Covalon Technologies

Covalon Technologies Ltd. is a Canadian company specializing in the innovation, development, manufacturing, and commercialization of medical technologies and products. With a strong presence in international markets, Covalon leverages proprietary technology platforms to address various healthcare needs.

Products and Services
  • Advanced wound care dressings for chronic and infected wounds
  • Antimicrobial silicone adhesive products for surgical applications
  • Unique medical coatings for existing medical devices
Growth Outlook
  • Recent quarterly revenue reached CAD 10.04 million, a significant increase
  • Trailing twelve months (TTM) revenue shows a strong upward trend
  • Expansion into new international markets is underway, enhancing growth potential
Financial Highlights
  • Net income for the latest quarter was CAD 2.81 million, reflecting strong profitability
  • TTM gross profit margin stands at 58.09%, indicating efficient operations
  • Current ratio of 8.56 suggests robust liquidity and financial health
Covalon Technologies Ltd. operates in the medical instruments and supplies industry, focusing on innovative solutions that cater to diverse healthcare needs. The company's product offerings are designed to improve patient outcomes and enhance the efficiency of healthcare providers. With a solid financial foundation, including a strong gross profit margin and significant net income, Covalon is well-positioned for future growth. The recent increase in quarterly revenue and ongoing expansion efforts further underscore the company's potential in the healthcare market. Investors may find Covalon's strategic initiatives and financial performance appealing as the company continues to innovate and expand its global footprint.
AI Generated • Sep 2, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Brent Ashton

Website

www.covalon.com

Headquarters

Mississauga, ON L4W 5S7, CA

COV Financials

Key Financial Metrics (TTM)

Gross Margin

58.09%

Operating Margin

11.49%

Net Income Margin

12.78%

Return on Equity

15.04%

Return on Capital

5.35%

Return on Assets

12.00%

Earnings Yield

3.99%

Dividend Yield

0.00%

Payout Ratio

94.41%

Stock Overview

Market Cap

CA$110.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

27.62M

Volume

93.10K

Avg. Volume

17.91K

Financials (TTM)

Gross Profit

CA$19.95M

Operating Income

CA$3.95M

EBITDA

CA$4.94M

Operating Cash Flow

CA$6.78M

Capital Expenditure

-CA$1.27M

Free Cash Flow

CA$5.51M

Cash & ST Invst.

CA$19.39M

Total Debt

CA$1.69M

Covalon Technologies Performance Analysis

Covalon Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30CAD 18,146,390-7.2%
20232023-09-30CAD 26,595,28646.6%
20242024-09-30CAD 31,168,53217.2%
20252025-09-30CAD 32,816,3475.3%
Covalon Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-303.8%
Q12025-12-31-20.8%
Q22026-03-3126.7%
Q32026-06-3015.1%
Covalon Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30CAD -0.38N/A
20232023-09-30CAD -0.18-52.2%
20242024-09-30CAD 0.11N/A
20252025-09-30CAD 0.07-31.0%
Covalon Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30469.6%
Q12025-12-31-65.6%
Q22026-03-31775.6%
Q32026-06-30153.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$10.04M

+19.9%

Gross Profit

CA$6.54M

+68.0%

Gross Margin

65.12%

N/A

Market Cap

CA$110.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$1.05M

N/A

Employees

105

N/A

Net Income

CA$2.81M

+4253.4%

EBITDA

CA$2.98M

+2072.1%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$19.39M

+7.2%

Total Debt

CA$1.69M

+32.0%

Accounts Receivable

CA$4.58M

-3.0%

Inventory

CA$7.10M

-11.8%

Long Term Debt

CA$1.35M

+84.0%

Short Term Debt

CA$339.88K

-37.7%

Return on Assets

12.00%

N/A

Return on Invested Capital

11.99%

N/A

Free Cash Flow

CA$2.55M

+48.8%

Operating Cash Flow

CA$2.85M

+32.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MIR.VMedMira Inc.
CA$0.07+0.00%
MBX.TOMicrobix Biosystems Inc.
CA$0.31+1.67%
SVA.TOSernova Corp.
CA$0.11+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$35.33-14.85%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$141.93+14.77%
GRMLGreenland Mines
$9.42+230.53%
INTCIntel
$121.78+12.14%

Questions About COV

What is the current price of Covalon Technologies?

Covalon Technologies is trading at CA$3.99 per share.

What is the 52-week range for Covalon Technologies?

Over the past 52 weeks, Covalon Technologies has traded between CA$1.55 and CA$4.01.

How much debt does Covalon Technologies have?

As of the most recent reporting period, Covalon Technologies reported total debt of CA$1.69M.

How much cash does Covalon Technologies have on hand?

Covalon Technologies reported CA$19.39M in cash and cash equivalents in its most recent financial results.

What is Covalon Technologies’s dividend yield?

Covalon Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services